Skip to content
Home/Companies/Biotech/Apogenix

Apogenix

Biotech·Germany·Active·21yr hold
Entry
2005
Hold
21yr
Status
Active

Who owns Apogenix?

Apogenix is currently owned by dievini Hopp BioTech holding through dievini Hopp BioTech holding (Evergreen Balance Sheet) (2005 vintage), since 2005.

Hand-verified · updated 2026-07-03

dievini Hopp BioTech holding
Investor
dievini Hopp BioTech holding
dievini Hopp BioTech holding (Evergreen Balance Sheet) · 2005 · Evergreen

Key facts

HQGermany
SectorBiotech
StatusActive

More from dievini Hopp BioTech holding (Evergreen Balance Sheet)

Other portfolio companies in the same fund.

Heidelberg Pharma
Heidelberg Pharma
Active
BiotechGermany· 2009
Novaliq
Novaliq
Active
PharmaGermany· 2007
Immatics
Immatics
Active
BiotechGermany· 2006
CureVac
CureVac
Exited 2025
BiotechGermany· 2005
to
Molecular Health
Active
SaaSGermany· 2004

More PE-backed in Biotech

Comparable biotech deals from other GPs.

Abbisko Healthcare
Active
The Carlyle GroupChina
Adagene
Active
General AtlanticChina
Advanced Cell Diagnostics
Active
Summit PartnersUS
Akero Therapeutics
Akero Therapeutics
Active
General AtlanticUS
Aldevron
Aldevron
Active
TA AssociatesUS
Alloy Therapeutics
Alloy Therapeutics
Active
Mubadala CapitalUS
Track Apogenix

Save this record to your watchlist and pick up your research where you left off. No spam.

Create free account

Who could buy Apogenix?

6 strategic and 114financial buyers match this company's sector and geography profile, ranked from verified European deal history.

Find likely buyers

Get the full record on Apogenix.

Free. No credit card. 30 seconds. Exit buyers and MOIC on Pro.

Hand-checked deal notes on this investment
Save this company to your watchlist
Exit buyers and MOIC on realized deals (Pro)
or
Continue with email

Already a member? Sign in

Look up another firm or company
Data refreshed weekly · Sourced from public filings · Report an issue